Chinook Therapeutics, Inc.

NasdaqGS:KDNY Stock Report

Market Cap: US$2.9b

Chinook Therapeutics, Inc. Company Information

Chinook Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Chinook Therapeutics, Inc.
  • Ticker: KDNY
  • Exchange: NasdaqGS
  • Founded: NaN
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$2.900b
  • Shares Outstanding: 71.80m
  • Website: https://www.chinooktx.com

Number of Employees

Location

  • Chinook Therapeutics, Inc.
  • 400 Fairview Avenue North
  • Suite 900
  • Seattle
  • Washington
  • 98109
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
290ADB (Deutsche Boerse AG)YesCommon SharesDEEUROct 2020
KDNYNasdaqGS (Nasdaq Global Select)YesCommon SharesUSUSDOct 2020

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2023/08/12 12:04
End of Day Share Price 2023/08/10 00:00
Earnings2023/06/30
Annual Earnings2022/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.